Christopher Barbieri

Company: Bristol Myers Squibb

Job title: Associate Director, Molecular Pharmacology & Screening Technology

Seminars:

Methods for the Discovery, Evaluation & Characterization of New Ligands for Targeted Protein Degradation 9:30 am

Identifying new E3 ligase interactions that can be harnessed against undruggable targets Generating actionable insights that can be used for further hit ID cascades Presenting methods for proximity labeling of a target of interest for identifying complex members and transient interactions Developing HTS methods to identify new molecules for targeted protein degradation Optimizing data analysis tools for…Read more

day: Conf Day 2

Panel Discussion – Comparing & Contrasting the Abilities of Phenotypic VS Target Based Screening 1:30 pm

Comparing phenotypic and target-based screening to reveal phenotypic approaches’ broad discovery potential versus the specificity of target-based methods Contrasting these methods to highlight phenotypic screening’s ability to uncover novel mechanisms of action, while target-based screening focuses on predefined molecular targets Discussing both approaches to underscore phenotypic screening’s relevance in identifying hits through functional therapeutic effects, compared to…Read more

day: Conf Day 2